4.7 Article

Fisetin regulates TPA-induced breast cell invasion by suppressing matrix metalloproteinase-9 activation via the PKC/ROS/MAPK pathways

Journal

EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 764, Issue -, Pages 79-86

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2015.06.038

Keywords

Fisetin; MMP-9; Invasion; PKC alpha; MCF-7

Funding

  1. National Research Foundation of Korea (NRF) Grant - Korea Government (MEST), Republic of Korea [2011-0030130, NRF-2013R1A1A 2007181]
  2. Korea Atomic Energy Research Institute [NRF-2015M2A2A6021673]

Ask authors/readers for more resources

Invasion and metastasis are among the main causes of death in patients with malignant tumors. Fisetin (3,3',4',7-tetrahydroxyflavone), a natural flavonoid found in the smoke tree (Cotinus coggygrio), is known to have antimetastatic effects on prostate and lung cancers; however, the effect of fisetin on breast cancer metastasis is unknown. The aim of this study was to determine the anti-invasive activity of fisetin in human breast cancer cells. Matrix metalloproteinase (MMP)-9 is a major component facilitating the invasion of many cancer tumor cell types, and thus the inhibitory effect of fisetin on MMP-9 expression in 12-O-tetradecanoylphorbol-13-acetate (TPA)-stimulated human breast cancer cells was investigated in this study. Fisetin significantly attenuated TPA-induced cell invasion in MCF-7 human breast cancer cells, and was found to inhibit the activation of the PKC alpha/ROS/ERK1/2 and p38 MAPK signaling pathways. This effect was furthermore associated with reduced NF-kappa B activation, suggesting that the anti-invasive effect of fisetin on MCF-7 cells may result from inhibited TPA activation of NF-kappa B and reduced TPA activation of PKCa/ROS/ERK1/2 and p38 MAPK signals, ultimately leading to the downregulation of MMP-9 expression. Our findings indicate the role of fisetin in MCF-7 cell invasion, and clarify the underlying molecular mechanisms of this role, suggesting fisetin as a potential chemopreventive agent for breast cancer metastasis. (C) 2015 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available